Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial (vol 372, pg 1174, 2008)
Journal Articles
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 18, 2008
has subject area
- 11 Medical and Health Sciences (FoR)
- General & Internal Medicine (Science Metrix)
published in
- The Lancet Journal